🇺🇸 FDA
Patent

US 9006203

Method of reducing inflammatory infiltration in subjects with inflammatory lung disease

granted A61PA61P11/00A61P11/08

Quick answer

US patent 9006203 (Method of reducing inflammatory infiltration in subjects with inflammatory lung disease) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Apr 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary of the Department of Health and Human Services
Grant date
Tue Apr 14 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61P, A61P11/00, A61P11/08, A61P11/10, A61P29/00